JW Pharmaceutical (XKRX:001060) E10: ₩692.61 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:001060 JW Pharmaceutical XKRX:001060
90 GF Score
Price ₩28,850.00
GF Value ₩32,148.31
Valuation Modestly Undervalued
View Full Analysis

What is JW Pharmaceutical E10?

JW Pharmaceutical XKRX:001060 +1.23% 90 E10 is ₩692.61 as of Mar. 2026. GuruFocus rates XKRX:001060 with a GF Score™ of 90/100 and a GF Value™ of ₩32,148.31 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

JW Pharmaceutical's adjusted earnings per share data for the three months ended in Mar. 2026 was ₩1,138.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩692.61 for the trailing ten years ended in Mar. 2026.

During the past 12 months, JW Pharmaceutical's average E10 Growth Rate was 73.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of JW Pharmaceutical was 33.30% per year. The lowest was -70.80% per year. And the median was -49.80% per year.

As of today (2026-08-18), JW Pharmaceutical's current stock price is ₩28850.00. JW Pharmaceutical's E10 for the quarter that ended in Mar. 2026 was ₩692.61. JW Pharmaceutical's Shiller PE Ratio of today is 41.65.

During the past 13 years, the highest Shiller PE Ratio of JW Pharmaceutical was 3486.85. The lowest was 33.93. And the median was 73.59.


JW Pharmaceutical  (XKRX:001060) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

JW Pharmaceutical's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=28850.00/692.61
=41.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of JW Pharmaceutical was 3486.85. The lowest was 33.93. And the median was 73.59.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


JW Pharmaceutical E10 Related Terms


JW Pharmaceutical E10 Historical Data

* Premium members only.

The historical data trend for JW Pharmaceutical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical E10 Chart

JW Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -350.67 -87.28 39.50 326.13 579.39

JW Pharmaceutical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 400.00 394.39 518.14 579.39 692.61

XKRX:001060 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Shiller PE Ratio falls into.


XKRX:001060
90GF Score
JW Pharmaceutical XKRX:001060
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JW Pharmaceutical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Pharmaceutical's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1138/125.2360*125.2360
=1,138.000

Current CPI (Mar. 2026) = 125.2360.

JW Pharmaceutical Quarterly Data

per share eps CPI Adj_EPS
201606 -699.343 100.791 -868.958
201609 -203.565 101.461 -251.265
201612 329.085 101.561 405.797
201703 27.629 102.851 33.642
201706 -52.746 102.611 -64.376
201709 218.520 103.491 264.436
201712 -256.337 102.991 -311.704
201803 172.505 104.101 207.528
201806 324.515 104.130 390.289
201809 82.837 105.651 98.193
201812 -287.178 104.351 -344.655
201903 -196.861 104.491 -235.945
201906 63.588 104.881 75.929
201909 47.909 105.200 57.033
201912 -952.719 105.121 -1,135.019
202003 -97.795 105.354 -116.250
202006 -337.346 105.112 -401.933
202009 116.636 106.198 137.546
202012 -277.844 105.765 -328.993
202103 159.872 107.357 186.496
202106 -133.996 107.579 -155.989
202109 202.381 108.759 233.041
202112 -267.281 109.676 -305.200
202203 375.976 111.848 420.980
202206 33.314 114.072 36.574
202209 323.625 114.715 353.305
202212 509.233 115.179 553.696
202303 630.392 116.507 677.620
202306 520.588 117.182 556.368
202309 -713.725 118.964 -751.356
202312 994.588 118.837 1,048.143
202403 816.000 120.123 850.731
202406 346.000 120.007 361.075
202409 807.000 120.861 836.211
202412 675.000 121.135 697.851
202503 714.000 122.590 729.411
202506 -77.000 122.611 -78.648
202509 1,267.000 123.402 1,285.833
202512 634.000 123.939 640.633
202603 1,138.000 125.236 1,138.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₩692.61 mean?
JW Pharmaceutical (XKRX:001060) has a E10 of ₩692.61 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on JW Pharmaceutical and its competitors.
Is JW Pharmaceutical's E10 too high?
JW Pharmaceutical's current E10 is ₩692.61. Overall, JW Pharmaceutical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JW Pharmaceutical's E10 compare to ZTS?
JW Pharmaceutical's E10 of ₩692.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on JW Pharmaceutical and its competitors. JW Pharmaceutical's current E10 is ₩692.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JW Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, JW Pharmaceutical (XKRX:001060) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩32,148.31, compared to a current price of ₩28,850.00 — trading 10.3% below its estimated fair value. The current E10 is ₩692.61. JW Pharmaceutical's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For JW Pharmaceutical (XKRX:001060), the current E10 is ₩692.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JW Pharmaceutical (XKRX:001060) Overvalued in 2026?

Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued. The current stock price of ₩28,850.00 is trading 10.3% below its estimated GF Value™ of ₩32,148.31. GuruFocus considers JW Pharmaceutical to be Modestly Undervalued.

Key valuation signals for XKRX:001060:

  • E10: ₩692.61
  • GF Value™: ₩32,148.31 vs. price of ₩28,850.00 (10.3% below fair value)
  • GF Score™: 90/100

No single metric tells the full story. See the XKRX:001060 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JW Pharmaceutical Business Description

Address 2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
90GF Score

Get the complete analysis for XKRX:001060

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩28,850.00
Price
₩32,148.31
GF Value